Efficacy and cost of high-frequency IGRT in elderly stage III non-small-cell lung cancer patients

BACKGROUND: High-frequency image-guided radiotherapy (hfIGRT) is ubiquitous but its benefits are unproven. We examined the cost effectiveness of hfIGRT in stage III non-small-cell lung cancer (NSCLC). METHODS: We selected stage III NSCLC patients ≥66 years old who received definitive radiation thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Heilbroner, Samuel P., Xanthopoulos, Eric P., Buono, Donna, Carrier, Daniel, Durkee, Ben Y., Corradetti, Michael, Wang, Tony J. C., Neugut, Alfred I., Hershman, Dawn L., Cheng, Simon K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158910/
https://www.ncbi.nlm.nih.gov/pubmed/34043677
http://dx.doi.org/10.1371/journal.pone.0252053

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8158910/
https://www.ncbi.nlm.nih.gov/pubmed/34043677
http://dx.doi.org/10.1371/journal.pone.0252053

Ejemplares similares